Is Bigger Better? Go Big or Go Home? The Role of Macroimplants Friday, October 10 Fri, Oct 10 5:00-6:00 p.m. CDT

As macroimplants emerge as a new frontier in aesthetic and reconstructive breast surgery, this session will critically examine their clinical implications, supported by data from a landmark 10-year, multi-institutional FDA trial. Faculty will explore the outcomes, design rationale, and evolving surgical indications for these larger-volume devices. Through case-based discussion, the panel will identify appropriate and inappropriate patient candidates, emphasizing anatomical, lifestyle, and safety considerations. The session will also cover devices that traditionally have been available for use in patients needing larger sizes. Attendees will gain insights into the pros and cons of macroimplants.

Upon completion of this learning activity, participants should be able to:

1. Discuss the outcomes of the design and outcomes of the prospective, multi-institutional, 10-year FDA trial
2. Identify patients who might be candidates for these devices and why
3. Identify patients who should not receive these devices and why; understand what devices might be appropriate for these patients
4. Discuss the potential long-term changes to the practice of plastic surgery that are likely to occur as a result of the introduction of these larger-volume devices
5. Outline the potential long-term risks and benefits that larger-volume breast implants pose to patients, particularly if indiscriminately employed by uninformed surgeons.